Status:
UNKNOWN
Selective RPE Laser Treatment (SRT) for Various Macular Diseases
Lead Sponsor:
University of Regensburg
Collaborating Sponsors:
Dr. Werner Jackstaedt Foundation
Conditions:
Age-Related Macular Degeneration
Diabetic Maculopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this prospective clinical study SRT is performed with various pulse durations at 1.7µs and additionally 200ns to evaluate the different clinical effects of both laser regimens. The macular diseases...
Detailed Description
Conventional laser photocoagulation has been shown to be beneficial in a variety of retinal diseases like age related macular degeneration (AMD), diabetic maculopathy (DMP), diabetic retinopathy (DRP)...
Eligibility Criteria
Inclusion
- symmetric drusen maculopathy with soft drusen both eyes
- symmetric geographic atrophy both eyes
- diabetic macular edema single eye
- acute or chronic central serous chorioretinopathy
Exclusion
- previous laser treatment
- previous intravitreal injections
- choroidal neovascularization
- visual acuity \> 0.1
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00403884
Start Date
October 1 2004
End Date
August 1 2010
Last Update
January 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Eye Hospital Regensburg
Regensburg, Germany, 93042